XML 54 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions (Details) - USD ($)
1 Months Ended 3 Months Ended
May 18, 2020
Apr. 12, 2019
Oct. 19, 2020
Sep. 30, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Acquisitions (Details) [Line Items]              
Cash   $ 500,000          
Agreed to earn-out provision, description   The fair value of the 3,968,254 common shares issued as part of the acquisition consideration was determined using the intraday volume weighted average price of the Company’s common shares on the acquisition date. The terms of the earn out require the Company to pay the former owner of HCFM up to $100,000, $200,000 and $200,000 on the first, second and third anniversary, respectively, based on achievement by NCFM of revenue of at least $3,100,000 (50% weighting) and EBITDA of at least $550,000 (50% weighting) in the year preceding each anniversary date.          
Transaction value $ 1,423,465 $ 1,764,672          
Fair value of website   41,000          
Fair value of patient management platform database   $ 1,101,538          
Percentage of capitalization rate         11.75%    
Percentage of sustainable growth rate         5.00%    
Description of acquisition     Key assumptions include (i) a discount rate of 23.48% (ii) sustainable growth of 3.00% and (iii) a benefit stream using EBITDA cash flow. The website is being amortized over a five-year expected life. Goodwill of $766,249 arising from the acquisition consists of value associated with the legacy name.   Significant factors considered in the calculation of the rate of return are the weighted average cost of capital and return on assets, as well as the risks inherent in the business. Cash flows were estimated based on EBITDA using forecasted revenue and costs. The measure is based on significant inputs that are not observable in the market (i.e. Level 3 inputs). Key assumptions include (i) a capitalization rate of 24.24% (ii) sustainable growth of 5.00% and (iii) a benefit stream using EBITDA cash flow. Goodwill of $381,856 arising from the acquisition consists of value associated with the legacy name. None of the goodwill recognized is expected to be deductible for income tax purposes.    
Business combination current earnout, description       During September 2020, pursuant to a Second Amendment to the Agreement and Plan of Merger and in satisfaction of the Current Earnout, the Company paid $90,389 cash, issued 1,835,625 shares and agreed that the balance of the Current Earnout that was not earned in 2020, being $124,043 cash and $366,300 in shares of Company common stock, would be deferred until the first future earnout year in which MSSP revenue exceeds $1.725 million and revenue from other services exceeds $605,000.      
Fair value of common shares issued     $ 3,538,000       $ 1,073,000
HCFM [Member]              
Acquisitions (Details) [Line Items]              
Acquired interest rate   100.00%          
Cash   $ 500,000          
Shares of common stock (in Shares)   3,968,254          
Agreed to earn-out provision, description   agreed to an earn-out provision of $500,000 that may be earned based on the performance of HCFM in the years ended on the first, second and third anniversary dates of the acquisition closing. The total consideration fair value represents a transaction value of $1,799,672. The Company accounted for the transaction as an acquisition of a business pursuant to ASC 805, “Business Combinations” (“ASC 805”).          
Losses on change in fair value of contingent acquisition consideration         $ 11,308 $ 6,621  
CHM [Member]              
Acquisitions (Details) [Line Items]              
Acquired interest rate 100.00%            
Agreed to earn-out provision, description Under the terms of acquisition, the Company paid CHM shareholders the following consideration: (i) $214,000 in cash paid at closing, (ii) 2,240,838 shares of HealthLynked common stock issued at closing, (iii) up to $223,500 additional cash and $660,000 in additional shares of HealthLynked common payable at the time CHM receives the final assessment of the calculation of MSSP savings for the 2019 program year, with this amount prorated based on a target MSSP payment (plus other ancillary revenue) of $1,725,000, and (iv) up to $437,500 based on the business achieving annual revenue of $2,250,000 and annual profit of $500,000 in each of the four years following closing.            
Losses on change in fair value of contingent acquisition consideration         33,252    
Description of acquisition The terms of the earn out require the Company to pay the former owners of CHM (i) up to $223,500 additional cash and to $660,000 of additional shares of Company common stock when CHM receives the final assessment of the calculation of 2019 plan year MSSP revenue (the “Current Earnout”), and (ii) up to $62,500, $125,000, $125,000 and $125,000 on the first, second, third and fourth anniversary, respectively, based on achievement by the underlying business of revenue of at least $2,250,000 (50% weighting) and profit of at least $500,000 (50% weighting) in the year preceding each anniversary date (the “Future Earnout”).            
MedOffice Direct LLC [Member]              
Acquisitions (Details) [Line Items]              
Acquired interest rate     100.00%        
Agreed to earn-out provision, description     Under the terms of acquisition, the Company paid the following consideration: (i) 19,045,563 shares of Company common stock issued at closing, (ii) partial satisfaction of certain outstanding debt obligations of MOD in the amount of $703,200 in cash paid by the Company, and (iii) up to 10,004,749 restricted shares of the Company’s common stock over a four-year period based on MOD achieving prescribed revenue targets in calendar years 2021 through 2024.        
Transaction value     $ 3,999,730        
Losses on change in fair value of contingent acquisition consideration         $ 591,140    
Description of acquisition     The terms of the earn out require the Company to issue to the former equity members of MOD up to 1,9688,448 shares, 3,154,264 shares, 2,631,195 shares and 2,250,842 shares, respectively, (the “MOD Earnout Shares”) based on achievement by the underlying business of revenue of at least $1,500,000 in 2021, $1,875,000 in 2022, $2,344,000 in 2023 and $2,930,000 in 2024.        
Fair value of common shares issued     $ 19,045,563        
Common Stock [Member] | HCFM [Member]              
Acquisitions (Details) [Line Items]              
Shares of common stock (in Shares)   3,968,254          
Common Stock [Member] | CHM [Member]              
Acquisitions (Details) [Line Items]              
Shares of common stock (in Shares) 2,240,838            
Dr. Michael Dent [Member]              
Acquisitions (Details) [Line Items]              
Shares of common stock (in Shares)         10,573,745    
Additional shares of common stock (in Shares)         5,554,452    
Cash repayment of debt         $ 457,200    
George O' Leary [Member]              
Acquisitions (Details) [Line Items]              
Shares of common stock (in Shares)         1,130,213    
Additional shares of common stock (in Shares)         593,707    
Cash repayment of debt         $ 66,000    
Mr. Gasparini [Member]              
Acquisitions (Details) [Line Items]              
Shares of common stock (in Shares)         99,437    
Additional shares of common stock (in Shares)         52,235